CD40 activation induces apoptosis in cultured human hepatocytes via induction of cell surface Fas ligand expression and amplifies Fas-mediated hepatocyte death during allograft rejection

Journal of Experimental Medicine

Volumn 189, Issue 2, 1999, Pages 441-446

  Afford, Simon C ^a,c   Randhawa, Satinder ^a   Eliopoulos, Aristides G ^b   Hubscher, Stefan G ^a   Young, Lawrence S ^b   Adams, David H ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

^c QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

Allograft rejection; Apoptosis; CD40 activation; Hepatocytes

Indexed keywords

CD40 ANTIGEN; CD68 ANTIGEN; FAS LIGAND;

APOPTOSIS; ARTICLE; CLINICAL ARTICLE; GENE EXPRESSION; GRAFT REJECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CELL; LIVER TRANSPLANTATION; MACROPHAGE; PRIORITY JOURNAL;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD40; APOPTOSIS; CELL LINE; FAS LIGAND PROTEIN; FLOW CYTOMETRY; GRAFT REJECTION; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LIVER; MEMBRANE GLYCOPROTEINS; MICROSCOPY, FLUORESCENCE; TRANSPLANTATION, HOMOLOGOUS;

EID: 0033579819     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.189.2.441     Document Type: Article

References (28)

1. Neuberger, J.M., and D.H. Adams. 1998. What is the significance of acute liver allograft rejection? J. Hepatol 29:143-150.
2. Hubscher, S. 1996. Diagnosis and grading of liver allograft rejection: a European perspective. Transplant. Proc. 28:504-507.
3. Afford, S.C., S. Hubscher, A.J. Strain, D.H. Adams, and J.M. Neuberger. 1995. Apoptosis in the human liver during allograft rejection and end stage liver disease. J. Pathot. 176: 373-380.
4. Krams, S.M., H. Egawa, M.B. Quinn, J.C. Villanueva, R. Garcia-Kennedt, and O.M. Martinez. 1995. Apoptosis as a mechanism of cell death in liver allograft rejection. Transplantation (Baltimore). 59:621-625.
5. Nagata, S., and P. Goldstein. 1995. The Fas death factor. Science. 267:1449-1456.
6. Stout, R.D., and J. Suttles. 1996. The many roles of CD40 in cell-mediated inflammatory responses. Immunol. Today. 17: 487-492.
7. Van Kooten, C., and J. Banchereau. 1997. Functions of CD40 on B cells, dendritic cells and other cells. Curr. Opin. Immunol. 9:330-337.
8. Hess, S., and H. Engelmann. 1996. A novel function of CD40: induction of cell death in transformed cells. J. Exp. Med. 183:159-167.
9. Ogasawara, J., R. Watanabe-Fukunaga, M. Adachi, A. Matsuzawa, T. Kasugai, Y. Kitamura, N. Itoh, T. Suda, and S. Nagata. 1993. Lethal effects of the anti-fas antibody in mice. Nature. 364:806-809.
10. Griffith, T.S., T. Brunner, S.M. Fletcher, D.R. Green, and T.A. Ferguson. 1995. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science. 270:1189-1192.
11. Lacronique, V., A. Mignon, M. Fahre, B. Viollet, N. Rouquet, T. Molina, A. Porteu, A. Henrion, D. Bouscary, P. Varlet, et al. 1996. Bcl-2 protects from lethal hepatic apoptosis induced by an anti-Fas antibody in mice. Nat. Med. 1:80-86.
12. Kondo, T., T. Suda, H. Fukuyama, M. Adachi, and S. Nagata. 1997. Essential roles of the Fas ligand in the development of hepatitis. Nat. Med. 4:409-413.
13. Guidotti, L.G., T. Ishikawa, M.V. Hobbs, B. Matzke, R. Schreiber, and F.V. Chiasari. 1996. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity. 1:25-36.
14. Strand, S., W.J. Hofmann, A. Grambihler, H. Hug, M. Volkmann, G. Otto, H. Wesch, S. Mariani, V. Hack, W. Stremmel, et al. 1998. Hepatic failure and liver cell damage in acute Wilson's disease involve CD95(Apo-1/Fas) mediated apoptosis. Nat. Med. 4:588-593.
15. Galle, P.R., W.J. Hofmann, H. Walczak, H. Schaller, G. Otto, W. Stremmel, P.H. Krammer, and L. Runkel. 1995. Involvement of the CD95 (Apo-1/Fas) receptor ligand in liver damage. J. Exp. Med. 182:1223-1230.
16. Eliopoulos, A.G., C.W. Dawson, G. Mosialos, J.E. Floettmann, M. Rowe, R.J. Armitage, J. Dawson, J.M. Zapata, D.J. Kerr, M.J.O. Wakelam, et al. 1996. CD40-induced growth inhibition in epithelial cells is mimicked by Epstein-Barr virus-encoded LMP1: involvement of TRAF3 as a common mediator. Oncogene. 13:2243-2254.
17. Caux, C., C. Massacrier, B. Vanbervliet, B. Dubois, C. Van Kooten, I. Durand, and J. Banchereau. 1994. Activation of human dendritic cells through CD40 cross-linking. J. Exp. Med. 180:1263-1272.
18. Hollenbaugh, D., N. Mischel-Petty, C.P. Edwards, J.C. Simon, R.W. Denfield, P.A. Kiener, and A. Aruffo. 1995. Expression of functional CD40 by vascular endothelial cells. J. Exp. Med. 182:33-40.
19. Ridge, J.P., F. Di Rosa, and P. Matzinger. 1998. A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell. Nature. 393:474-478.
20. Young, L.S., A.G. Eliopoulos, N.J. Gallagher, and C.W. Dawson. 1998. CD40 and epithelial cells: across the great divide. Immunol. Today. 19:502-506.
21. Adams, D.H., S.G. Hubscher, J. Shaw, G.D. Johnson, C. Babbs, R. Rothlein, and J.M. Neuberger. 1991. Increased expression of ICAM-1 on bile ducts in primary biliary cirrhosis and primary sclerosing cholangitis. Hepatology. 14:426-432.
22. Strain, A.J., T. Ismail, H. Tsubouchi, T. Hishida, N. Kitamura, Y. Daikuhara, and P. McMaster. 1991. Native and recombinant human hepatocyte growth factor are highly potent promoters of DNA synthesis in both human and rat hepatocytes. J. Clin. Invest. 87:1853-1857.
23. Adams, D.H., G. Luce, S. Shaw. 1995. Database, Fifth International Workshop on Leukocyte Differentiation Antigens. http:/www.nci.nih.gov/intra/eib/Shaw.htm
24. Ansari, B., P.J. Coates, B.D. Greenstein, and P.A. Hall. 1993. In situ end labeling detects DNA strand breaks in apoptosis and other physiological and pathological states. J. Pathol. 170: 1-8.
25. Yoong, K.F., S.G. Hubscher, and D.H. Adams. 1998. Vascular adhesion protein-1 and ICAM-1 support the adhesion of tumor infiltrating lymphocytes to tumor endothelium in human hepatocellular carcinoma. J. Immunol. 160:3978-3988.
26. Loweth, A.C., G.T. Williams, R.F. James, J.H. Scarpello, and N.G. Morgan. 1998. Human islets of Langerhans express Fas ligand and undergo apoptosis in response to interleukin 1 beta and Fas ligation. Diabetes. 47:727-732.
27. Steinhoff, G., M. Behrend, B. Schrader, A.M. Duijvestijn, and K. Wonigeit. 1993. Expression patterns of leukocyte adhesion ligand molecules on human liver endothelia. Lack of ELAM-1 and CD62 inducibility on sinusoidal endothelia and distinct distribution of VCAM-1, ICAM-1, ICAM-2, and LFA-3. Am. J. Pathol. 142:481-488.
28. Adams, D.H., S.G. Hubscher, J. Shaw, R. Rothlein, and J.M. Neuberger. 1989. Intercellular adhesion molecule 1 on liver allografts during rejection. Lancet. 2:1122-1125.